SE466481B - Analgetiska och anti-inflammatoriska kompositioner innefattande koffein - Google Patents

Analgetiska och anti-inflammatoriska kompositioner innefattande koffein

Info

Publication number
SE466481B
SE466481B SE8401538A SE8401538A SE466481B SE 466481 B SE466481 B SE 466481B SE 8401538 A SE8401538 A SE 8401538A SE 8401538 A SE8401538 A SE 8401538A SE 466481 B SE466481 B SE 466481B
Authority
SE
Sweden
Prior art keywords
caffeine
analgesic
composition according
narcotic
pharmaceutically acceptable
Prior art date
Application number
SE8401538A
Other languages
English (en)
Swedish (sv)
Other versions
SE8401538L (sv
SE8401538D0 (sv
Inventor
A Sunshine
E M Laska
C E Siegel
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of SE8401538L publication Critical patent/SE8401538L/xx
Publication of SE8401538D0 publication Critical patent/SE8401538D0/xx
Publication of SE466481B publication Critical patent/SE466481B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE8401538A 1982-07-22 1984-03-20 Analgetiska och anti-inflammatoriska kompositioner innefattande koffein SE466481B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
PCT/US1983/001121 WO1984000488A1 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Publications (3)

Publication Number Publication Date
SE8401538L SE8401538L (sv) 1984-03-20
SE8401538D0 SE8401538D0 (sv) 1984-03-20
SE466481B true SE466481B (sv) 1992-02-24

Family

ID=23584242

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401538A SE466481B (sv) 1982-07-22 1984-03-20 Analgetiska och anti-inflammatoriska kompositioner innefattande koffein

Country Status (15)

Country Link
JP (3) JPS59501460A (de)
AT (2) AT389226B (de)
AU (1) AU558485B2 (de)
BE (1) BE897356A (de)
CA (1) CA1217429A (de)
CH (1) CH659391A5 (de)
DE (1) DE3390116C2 (de)
FR (1) FR2530469A1 (de)
GB (1) GB2134786B (de)
IE (1) IE55367B1 (de)
IT (1) IT1206502B (de)
NL (1) NL191432C (de)
SE (1) SE466481B (de)
WO (1) WO1984000488A1 (de)
ZA (2) ZA835324B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
CH669523A5 (de) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
KR20030034171A (ko) 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. 옥시모르폰 제어 방출 제형
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (ja) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd 疲労回復剤
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP2018076305A (ja) * 2016-10-31 2018-05-17 エスエス製薬株式会社 医薬組成物
JP6811453B1 (ja) * 2020-06-24 2021-01-13 医療法人すぎやま内科 経皮吸収用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Also Published As

Publication number Publication date
AT389998B (de) 1990-02-26
DE3390116T1 (de) 1985-01-10
WO1984000488A1 (en) 1984-02-16
SE8401538L (sv) 1984-03-20
NL8320240A (nl) 1984-06-01
GB8406704D0 (en) 1984-04-18
AT389226B (de) 1989-11-10
IE831715L (en) 1984-01-22
CA1217429A (en) 1987-02-03
DE3390116C2 (de) 1994-06-16
JPS59501459A (ja) 1984-08-16
GB2134786A (en) 1984-08-22
JPH07165583A (ja) 1995-06-27
ZA835326B (en) 1984-09-26
AU558485B2 (en) 1987-01-29
BE897356A (fr) 1983-11-14
FR2530469A1 (fr) 1984-01-27
SE8401538D0 (sv) 1984-03-20
IT8322173A0 (it) 1983-07-21
IT1206502B (it) 1989-04-27
NL191432B (nl) 1995-03-01
CH659391A5 (de) 1987-01-30
GB2134786B (en) 1986-05-08
ZA835324B (en) 1984-09-26
NL191432C (nl) 1995-07-04
AU1881683A (en) 1984-02-23
JPS59501460A (ja) 1984-08-16
ATA903983A (de) 1989-04-15
ATA245988A (de) 1989-08-15
IE55367B1 (en) 1990-08-29

Similar Documents

Publication Publication Date Title
EP0114886B1 (de) Analgetische und entzündungshemmende zusammensetzungen mit gehalt an kaffein
EP0165308B1 (de) Analgesische und antientzündende zusammensetzung, enthaltend xanthine sowie deren verwendungsverfahren
US6187338B1 (en) Anticonvulsant containing composition for treating neuropathic pain
US4567183A (en) Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
JP2000508341A (ja) 片頭痛の治療法及び薬効の強化組成物
US4420483A (en) Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4464376A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
SE466481B (sv) Analgetiska och anti-inflammatoriska kompositioner innefattande koffein
FR2559061A1 (fr) Compositions analgesiques et anti-inflammatoires contenant de la diphenhydramine
US4656177A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4777174A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4587249A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4479956A (en) Analgesic compositions comprising propiram and methods of using same
EP0514023B1 (de) Verwendung Glycine/NMDA-Rezeptorliganden zur Herstellung eines Arzneimittels zur Behandlung von Drogenabhängigkeit und Entzugserscheinungen
US4576951A (en) Proglumide, pharmaceutical preparations and compositions including it for use in human pain relief
CA1141664A (en) Analgesic composition
JPH11513386A (ja) β−受容体遮断薬とオピオイドとの新規な組合せ物
RU2213561C2 (ru) Болеутоляющие композиции, содержащие ненаркотический анальгетик и усилитель анальгезии

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401538-7

Format of ref document f/p: F

NUG Patent has lapsed